The condom is actually a vaginal gel which is liquid at room temperature, becomes gelatinous at body temperature, and contains anti-HIV drugs which are released in the presence of semen. The technical term for it is a microbicide.
The work was published last year in the Journal of Pharmaceutical Sciences. The technology was developed by professor Patrick Kiser and Kavita Madanlal Gupta, a Utah graduate student from India. (Picture of Patrick Kiser from the University of Utah.)
Given how quickly this research has been commercialized, halfway around the world, the deal stands as an object lesson in both the medical industry and in international relations. The researchers hope to have a product out on the market within four years.